NucleIQ® CS-BC-HER2 Algorithm for HER2 Detection in Breast Cancer

Breast Cancer

Automation and Precision in Detection

Automatically detects and quantifies HER2-positive cells, delivering precise and consistent results for cancer screening in breast tissue samples

Reduction of Interpretation Variability

Reduces subjective variability, providing a more objective and quantitative assessment.

Intuitive and Clear Visualization of Results

Displays detections as overlay layers on the image, facilitating interpretation and in-depth analysis.

Efficient Workflow

Optimizes diagnostic time, improving efficiency and streamlining the analysis process.

Consistent and Reproducible Results

Facilitates long-term comparison and tracking of results across different samples.
Access to the website

The information on this website is intended exclusively for healthcare professionals; this content is not intended for the general public.